Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Bluejay Diagnostics (BJDX) EBIAT (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed EBIAT for 2 consecutive years, with -$2.3 million as the latest value for Q4 2023.

  • Quarterly EBIAT rose 3.5% to -$2.3 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$10.0 million through Dec 2023, down 7.07% year-over-year, with the annual reading at -$6.8 million for FY2025, 11.26% up from the prior year.
  • EBIAT hit -$2.3 million in Q4 2023 for Bluejay Diagnostics, roughly flat from -$2.3 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of -$1.9 million in Q2 2022 to a low of -$3.0 million in Q3 2022.